3-aminobenzamide has been researched along with Anterior Choroidal Artery Infarction in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The authors examined whether genetic deletion of PARP (PARP null mice) or its pharmacologic inhibition by 3-aminobenzamide (3-AB) attenuates tissue injury after transient cerebral ischemia." | 3.69 | Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. ( Endres, M; Moskowitz, MA; Namura, S; Waeber, C; Wang, ZQ, 1997) |
| "However, in cerebral ischemia, excessive PARS activation may lead to energy depletion and exacerbation of neuronal damage." | 1.31 | Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain. ( Ben-Ari, Y; Benjelloun, N; Charriaut-Marlangue, C; Ducrocq, S; Plotkine, M, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hortobágyi, T | 1 |
| Görlach, C | 1 |
| Benyó, Z | 1 |
| Lacza, Z | 1 |
| Hortobágyi, S | 1 |
| Wahl, M | 1 |
| Harkany, T | 1 |
| Yap, E | 1 |
| Tan, WL | 1 |
| Ng, I | 1 |
| Ng, YK | 1 |
| Endres, M | 1 |
| Wang, ZQ | 1 |
| Namura, S | 1 |
| Waeber, C | 1 |
| Moskowitz, MA | 1 |
| Tokime, T | 1 |
| Nozaki, K | 1 |
| Sugino, T | 1 |
| Kikuchi, H | 1 |
| Hashimoto, N | 1 |
| Ueda, K | 1 |
| Ducrocq, S | 1 |
| Benjelloun, N | 1 |
| Plotkine, M | 1 |
| Ben-Ari, Y | 1 |
| Charriaut-Marlangue, C | 1 |
| Ding, Y | 1 |
| Zhou, Y | 1 |
| Lai, Q | 1 |
| Li, J | 1 |
| Gordon, V | 1 |
| Diaz, FG | 1 |
6 other studies available for 3-aminobenzamide and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Inhibition of neuronal nitric oxide synthase-mediated activation of poly(ADP-ribose) polymerase in traumatic brain injury: neuroprotection by 3-aminobenzamide.
Topics: Animals; Benzamides; Brain Injuries; Cerebral Infarction; Cold Temperature; Down-Regulation; Drug In | 2003 |
Combinatorial-approached neuroprotection using pan-caspase inhibitor and poly (ADP-ribose) polymerase (PARP) inhibitor following experimental stroke in rats; is there additional benefit?
Topics: Adenosine Triphosphate; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Benzamides; Caspases; C | 2008 |
Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Topics: Animals; Benzamides; Brain; Brain Damage, Chronic; Brain Ischemia; Cerebral Infarction; DNA Damage; | 1997 |
Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain.
Topics: Animals; Benzamides; Cerebral Infarction; Enzyme Inhibitors; Immunohistochemistry; Indazoles; Ischem | 1998 |
Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain.
Topics: Animals; Animals, Newborn; Benzamides; Brain Ischemia; Cell Death; Cerebral Infarction; Encephalitis | 2000 |
Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment.
Topics: Animals; Benzamides; Cerebral Infarction; Cerebrovascular Circulation; Enzyme Inhibitors; Female; In | 2001 |